A Long-term Safety Study of QMF149 in Japanese Participants With Asthma
NCT03100500
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
51
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
DRUG:
QMF149
Sponsor
Novartis Pharmaceuticals